Yayın: Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study
| dc.contributor.author | İlhan, O. | |
| dc.contributor.author | Özcan, Mühit | |
| dc.contributor.author | Yalçın, Arzu | |
| dc.contributor.author | Koç, H. | |
| dc.contributor.author | Beksaç, Mehmet | |
| dc.contributor.author | Ünal, Ali | |
| dc.contributor.author | Gülbaş, Zafer | |
| dc.contributor.author | Gürman, Günhan | |
| dc.contributor.author | Dündar, Semra | |
| dc.contributor.author | Ündar, Levent | |
| dc.contributor.author | Payzin, Bahriye | |
| dc.contributor.author | Akan, H. | |
| dc.contributor.buuauthor | Tunalı, Ahmet | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Hemotoloji Ana Bilim Dalı | |
| dc.date.accessioned | 2022-03-15T07:20:53Z | |
| dc.date.available | 2022-03-15T07:20:53Z | |
| dc.date.issued | 1997-11-15 | |
| dc.identifier.citation | İlhan, O. vd. (1997). "Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study". Blood, 90(10), Supplement 1, Part 2, 3999-3999. | |
| dc.identifier.endpage | 3999 | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issue | 10, Supplement 1, Part 2, | |
| dc.identifier.startpage | 3999 | |
| dc.identifier.uri | https://ashpublications.org/blood/issue/90/10 | |
| dc.identifier.uri | http://hdl.handle.net/11452/25023 | |
| dc.identifier.volume | 90 | |
| dc.identifier.wos | A1997YG42501308 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Amer Soc Hematology | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.collaboration | Sanayi | |
| dc.relation.journal | Blood | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Hematology | |
| dc.subject.wos | Hematology | |
| dc.title | Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dc.wos.quartile | Q1 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Hemotoloji Ana Bilim Dalı | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
